Diagnosis of migraine with aura, depression and anxiety from allelic variations in dopaminergic genes
CA 2263149 A1 · Owner: Peroutka, Stephen J. · Inventors: Peroutka, Stephen J.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention provides methods of diagnosing a syndrome characterized by symptoms of migraine with aura, depression and/or anxiety. Diagnosis entails detecting a variant form of one or more dopaminergic genes such as DRD1, DRD2, DRD3 and DAT. Methods of screening for therapeutic agents effective to treat the syndrome and methods of treatment are also provided.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 21, 1997. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 21, 2017.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 21, 2019.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.